Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI-driven Multiomics Research on Precise Typing and Response Prediction of Luminal Breast Cancer

NCT07692230 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07692230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07692230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI-driven Multiomics Research on Precise Typing and Response Prediction of Luminal Breast Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Active, not recruiting
Start date
January 6, 2026
Completion date
December 31, 2029
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hr positive/her-2 negative breast cancer